Literature DB >> 8806435

Programmed myocyte cell death affects the viable myocardium after infarction in rats.

W Cheng1, J Kajstura, J A Nitahara, B Li, K Reiss, Y Liu, W A Clark, S Krajewski, J C Reed, G Olivetti, P Anversa.   

Abstract

To determine whether apoptotic and necrotic myocyte cell death occur acutely and chronically after infarction, the formation of DNA strand breaks and the localization of myosin monoclonal antibody labeling were analyzed in the surviving myocardium from 20 min to 1 month. DNA strand breaks in myocyte nuclei were detected as early as 3 h following coronary artery occlusion and were still present at 1 month. This cellular process was characterized biochemically by internucleosomal DNA fragmentation which produced DNA laddering on agarose gel electrophoresis. Quantitatively, 155 myocyte nuclei per 10(6) cells exhibited DNA strand breaks in the portion adjacent to the infarcted tissue at 3-12 h. This parameter increased to 704 at 1-2 days and subsequently decreased to 364 at 7 days, 188 at 14 days, and 204 at 1 month. In the remote myocardium, the number of myocyte nuclei with DNA strand breaks was 84 per 10(6) at 3-12 h and remained essentially constant up to 1 month. Programmed myocyte cell death was accompanied by a decrease in the expression of bcl-2 and an increase in the expression of bax. The changes in the expression of these genes were present at 1 and 7 days after coronary artery occlusion. In conclusion, the mechanical load produced by myocardial infarction and ventricular failure may affect the regulation of bcl-2 and bax in the viable myocytes, triggering programmed cell death and the remodeling of the ventricular wall.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806435     DOI: 10.1006/excr.1996.0232

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  64 in total

Review 1.  Control of apoptosis of cardiovascular fibroblasts: a novel drug target.

Authors:  H Rupp; B Maisch
Journal:  Herz       Date:  1999-05       Impact factor: 1.443

2.  Relation between circulating soluble Fas ligand and subsequent ventricular remodelling following myocardial infarction.

Authors:  T Soeki; Y Tamura; H Shinohara; K Sakabe; Y Onose; N Fukuda
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

Review 3.  Apoptosis in myocardial ischaemia and infarction.

Authors:  P A J Krijnen; R Nijmeijer; C J L M Meijer; C A Visser; C E Hack; H W M Niessen
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

4.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy.

Authors:  Q Li; B Li; X Wang; A Leri; K P Jana; Y Liu; J Kajstura; R Baserga; P Anversa
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

5.  Cell death, tissue hypoxia and the progression of heart failure.

Authors:  H N Sabbah; V G Sharov; S Goldstein
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

6.  Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction.

Authors:  Young-sup Yoon; Andrea Wecker; Lindsay Heyd; Jong-Seon Park; Tengiz Tkebuchava; Kengo Kusano; Allison Hanley; Heather Scadova; Gangjian Qin; Dong-Hyun Cha; Kirby L Johnson; Ryuichi Aikawa; Takayuki Asahara; Douglas W Losordo
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

7.  Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction.

Authors:  Shin-ichiro Ueda; Sho-ichi Yamagishi; Takanori Matsui; Yuko Jinnouchi; Tsutomu Imaizumi
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

8.  Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinases.

Authors:  Michela Capano; Martin Crompton
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

Review 9.  RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.

Authors:  Christian Werner; Magnus Baumhäkel; Koon K Teo; Roland Schmieder; Johannes Mann; Thomas Unger; Salim Yusuf; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2008-05-03       Impact factor: 5.460

Review 10.  The rationale for cardiomyocyte resuscitation in myocardial salvage.

Authors:  Gerald W Dorn; Abhinav Diwan
Journal:  J Mol Med (Berl)       Date:  2008-06-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.